We are live on ! Find out more
EV

Eclipse Ventures Portfolio holdings

AUM $2.57B
This Fund
S&P 500
This Quarter Est. Return
-34.74%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$111M
AUM Growth
-$157M
Cap. Flow
-$70.3M
Cap. Flow %
-63.36%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ENVX icon
Enovix
ENVX
+$70.3M

Sector Composition

Rank Sector Weight
1 Industrials 85.02%
2 Healthcare 14.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENVX icon
1
Enovix
ENVX
$737M
$94.3M 85.02%
8,666,581
-5,714,285
-40% -$70.3M
OWLT icon
2
Owlet
OWLT
$146M
$15.9M 14.35%
2,035,167
LHDX
3
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$691K 0.62%
6,223,795

Similar funds

Eclipse Ventures's Q4 2022 Portfolio in Review

As of Q4 2022, Eclipse Ventures held 3 positions worth $111M, down 59% from $268M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Eclipse Ventures withdrew a net $70.3M in Q4 2022, reducing 1 holding. Its largest reduction was Enovix, cutting an estimated $70.3M.

By sector, the portfolio is most concentrated in Industrials at 85% of assets, down from 86% a quarter earlier, followed by Healthcare.

  • Eclipse Ventures's biggest Q4 2022 reduction was Enovix, cutting an estimated $70.3M.
  • Eclipse Ventures's ten largest holdings make up 100% of its $111M portfolio in Q4 2022.
  • Eclipse Ventures opened 0 new positions and closed 0 in Q4 2022.
  • Eclipse Ventures's portfolio value fell 59% quarter-over-quarter to $111M.

Based on Eclipse Ventures's 13F filing for Q4 2022, filed 7 Feb 2023.